Paper Details

  1. Home
  2. Paper Details

Antiemetic Drugs Compatibility Evaluation with Paediatric Parenteral Nutrition Admixtures.

Author: ChmielewskiMaciej, JelińskaAnna, SzkudlarekJagoda, TomczakSzymon

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

Ondansetron, dexamethasone, and hydrocortisone, commonly used antiemetics, are compatible with various pediatric parenteral nutrition admixtures (PNAs), including those with different amino acid sources and injectable lipid emulsions. This finding supports the safe co-administration of these antiemetics with PNAs for managing chemotherapy-induced nausea and vomiting.
Paper Details　
Original Abstract of the Article :
Chemotherapy-induced nausea and vomiting are defined as the most common of side effects of treatment and, at the same time, are very difficult to accept for patients', frequently causing changes in the therapy regimen, significantly reducing its effectiveness. Thus, an antiemetic prophylactic is ess...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459602/

データ提供：米国国立医学図書館（NLM）

Antiemetic Drug Compatibility Evaluation with Paediatric Parenteral Nutrition Admixtures

The study focuses on the safe and effective administration of antiemetic drugs in pediatric patients undergoing chemotherapy. Chemotherapy-induced nausea and vomiting are common side effects, impacting patient well-being and treatment adherence. The researchers aimed to assess the compatibility of three common antiemetic drugs (ondansetron, dexamethasone, and hydrocortisone) with various pediatric parenteral nutrition admixtures (PNAs) to ensure safe and effective co-administration. Their findings revealed that all tested PNAs exhibited stability when co-administered with the antiemetic drugs, indicating a safe and compatible combination for pediatric patients.

Safe and Effective Antiemetic Therapy for Pediatric Cancer Patients

This research provides valuable insights into the safe and effective co-administration of antiemetics with PNAs in pediatric cancer patients. The compatibility of these drug combinations offers reassurance to healthcare professionals and parents, enabling the safe and efficient delivery of antiemetic therapy.

Navigating the Challenges of Pediatric Cancer Treatment

Pediatric cancer treatment is a complex journey, often fraught with challenges. This study offers a glimmer of hope by ensuring the safe and effective co-administration of essential medications. Remember, dear readers, supporting pediatric cancer patients requires a holistic approach that encompasses both medical treatment and emotional well-being.

Dr. Camel's Conclusion

Just as a camel navigates a desert filled with challenges, pediatric cancer treatment requires navigating a complex and often daunting landscape. This research offers a valuable insight into the safe administration of antiemetics, making the journey a little smoother for both patients and caregivers. Always remember, dear readers, compassion and scientific knowledge are essential tools for navigating the complexities of pediatric cancer treatment.

Date :
  1. Date Completed n.d.
  2. Date Revised 2023-08-29
Further Info :

Pubmed ID

37631357

DOI: Digital Object Identifier

PMC10459602

Related Literature

Article Analysis
・Side Effects of hydrocortisone
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.